-
Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer.
Genes Chromosomes Cancer. 1994 Jan;9(1):42-8
PMID: 7507699
-
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
Blood. 1999 Mar 1;93(5):1677-83
PMID: 10029597
-
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Oncogene. 2005 Nov 10;24(49):7281-9
PMID: 16027731
-
Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways.
Int J Cancer. 2007 Sep 15;121(6):1265-73
PMID: 17520678
-
MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Int J Cancer. 2002 Dec 20;102(6):608-14
PMID: 12448002
-
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.
Cancer Res. 2006 Dec 15;66(24):11632-43
PMID: 17178857
-
Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model.
J Cell Biol. 2005 Nov 21;171(4):663-73
PMID: 16301332
-
High-resolution genomic and expression analyses of copy number alterations in breast tumors.
Genes Chromosomes Cancer. 2008 Jun;47(6):530-42
PMID: 18335499
-
Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
Cancer Res. 2003 Jan 15;63(2):424-31
PMID: 12543798
-
Genome screening by comparative genomic hybridization.
Trends Genet. 1997 Oct;13(10):405-9
PMID: 9351342
-
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell. 2006 Dec;10(6):515-27
PMID: 17157791
-
Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
Stat Appl Genet Mol Biol. 2004;3:Article3
PMID: 16646809
-
Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
Oral Oncol. 1997 Jan;33(1):42-6
PMID: 9192552
-
Human breast cancer cell lines as models of growth regulation and disease progression.
J Mammary Gland Biol Neoplasia. 1996 Jan;1(1):111-21
PMID: 10887484
-
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12
PMID: 18077431
-
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Cancer Res. 2008 Sep 1;68(17):7165-75
PMID: 18757432
-
Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
Cancer Genet Cytogenet. 2004 Nov;155(1):57-62
PMID: 15527903
-
Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Anticancer Res. 1997 Nov-Dec;17(6D):4387-94
PMID: 9494538
-
Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
Genes Chromosomes Cancer. 2007 May;46(5):427-39
PMID: 17285574
-
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.
Oncogene. 2005 Jun 16;24(26):4232-42
PMID: 15824737
-
Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
Cancer Res. 1993 Feb 1;53(3):627-35
PMID: 8425198
-
Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.
Cytogenet Cell Genet. 1997;79(1-2):125-31
PMID: 9533029
-
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
Clin Cancer Res. 2006 Nov 15;12(22):6652-62
PMID: 17121884
-
Integrated profiling of basal and luminal breast cancers.
Cancer Res. 2007 Dec 15;67(24):11565-75
PMID: 18089785
-
Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer.
Cancer Res. 2007 Jan 15;67(2):818-26
PMID: 17234794
-
Breast tumor copy number aberration phenotypes and genomic instability.
BMC Cancer. 2006 Apr 18;6:96
PMID: 16620391
-
Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma.
Breast Cancer Res Treat. 2001 Feb;65(3):225-32
PMID: 11336244
-
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
Oncogene. 2005 Aug 4;24(33):5235-45
PMID: 15897872
-
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.
Cancer Res. 2004 Dec 1;64(23):8541-9
PMID: 15574760
-
Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
Exp Mol Pathol. 2006 Oct;81(2):115-22
PMID: 16919268
-
Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
Cancer Res. 2000 Feb 15;60(4):1077-83
PMID: 10706127
-
Shaping of tumor and drug-resistant genomes by instability and selection.
Oncogene. 2003 Jul 10;22(28):4370-9
PMID: 12853973
-
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
Cancer Res. 2004 Jan 1;64(1):40-7
PMID: 14729606
-
Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
Breast Cancer Res. 2004;6(5):R531-9
PMID: 15318934
-
CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
Genes Chromosomes Cancer. 1998 Aug;22(4):268-77
PMID: 9669664
-
Genomic analysis of the 8p11-12 amplicon in familial breast cancer.
Int J Cancer. 2007 Feb 1;120(3):714-7
PMID: 17096335
-
p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
Cancer Res. 2007 Oct 15;67(20):9862-8
PMID: 17942917
-
Assembly of microarrays for genome-wide measurement of DNA copy number.
Nat Genet. 2001 Nov;29(3):263-4
PMID: 11687795
-
Comprehensive profiling of 8p11-12 amplification in breast cancer.
Mol Cancer Res. 2005 Dec;3(12):655-67
PMID: 16380503
-
Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
Clin Cancer Res. 2004 Sep 1;10(17):5785-91
PMID: 15355907
-
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
BMC Cancer. 2006 Oct 13;6:245
PMID: 17040570
-
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Cancer Cell. 2006 Dec;10(6):529-41
PMID: 17157792